...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: AHA 2018
3
Nov 09, 2018 08:43AM
1
Nov 09, 2018 12:43PM
4
Nov 10, 2018 05:02PM
4
bfw
Nov 10, 2018 06:45PM
4
Nov 10, 2018 10:13PM
5
Nov 10, 2018 11:04PM
3
Nov 11, 2018 05:03AM
1
Nov 11, 2018 08:05AM
2
Nov 11, 2018 08:53AM
1
Nov 11, 2018 10:17AM

Bear

Totally agree ; Jelis data cleaner and Reduce absolutely confirms EPA as effective . The degree of difference is the only issue and FDA will allow what they allow for claims. I would call your attention to CXA-10 in P2 for PAH. I very strongly believe that nitrated Pufas will very shortly leapfrog all of the current class of omega 3’s , 6’s etc. etc.. that are the current rage. Nitrated Pufas share a number of pathways with RVX 208, such as Nfkb and Nrf2 as I have previously pointed to. Will Amarin buy Acasti out ? Will Astra buy both ? I think the entire space is too immature and the risk of being made obsolete too great . Just all my 2 Cents.

Thank you for all your great contributions !

Top

 

 

3
Nov 11, 2018 03:21PM
5
Nov 11, 2018 09:56PM
4
Nov 11, 2018 11:46PM
4
Nov 12, 2018 07:32AM
2
Nov 12, 2018 08:07AM
4
Nov 12, 2018 09:22AM
1
Nov 12, 2018 11:29AM
3
Nov 12, 2018 11:49AM
2
Nov 12, 2018 08:48PM
Share
New Message
Please login to post a reply